Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammationChi Kin Wong, Daniel J. Drucker, Theodore J. Brown et al.|Cell Metabolism|2023Cited by 251
Divergent roles for the gut intraepithelial lymphocyte GLP-1R in control of metabolism, microbiota, and T cell-induced inflammationChi Kin Wong, Daniel J. Drucker, Bernardo Yusta et al.|Cell Metabolism|2022Cited by 121
GIPR Is Predominantly Localized to Nonadipocyte Cell Types Within White Adipose TissueJonathan E. Campbell, Daniel J. Drucker, Jacqueline L. Beaudry et al.|Diabetes|2022Cited by 62
The GLP-1 medicines semaglutide and tirzepatide do not alter disease-related pathology, behaviour or cognitive function in 5XFAD and APP/PS1 miceLeticia Forny Germano, Daniel J. Drucker, Jacqueline A. Koehler et al.|Molecular Metabolism|2024Cited by 37
Glucose-dependent insulinotropic polypeptide receptor signaling alleviates gut inflammation in miceRola Hammoud, Daniel J. Drucker, Frank Reimann et al.|JCI Insight|2024Cited by 20